Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
University of Alabama at Birmingham
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
AstraZeneca
AstraZeneca
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Johns Hopkins University
Novartis
Institut National de la Santé Et de la Recherche Médicale, France
University of Alabama at Birmingham
St. Jude Children's Research Hospital
AstraZeneca
Masonic Cancer Center, University of Minnesota
AstraZeneca
Johns Hopkins University
Boston Children's Hospital
West China Hospital
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital